Trump Admin Reschedules State-Licensed Marijuana to Open Research Path

Acting Attorney General Todd Blanche announced that FDA-approved and state-licensed marijuana will be moved from Schedule I to Schedule III, initiating an expedited hearing to fully reschedule the substance; the move is aimed at expanding research and patient care, though it does not yet apply to marijuana generally. It follows a separate executive order from Trump to speed the review of psychedelic therapies, signaling broader reforms to medical research and treatment.